Browse studies

Find your next paid study

27,407 recruiting studies available now

Pathophysiology of Pharyngo-esophageal Junction and Esophageal Mechanisms Preventing Pharyngeal Reflux of Gastric Content

The overall goal is to define and characterize the manometric characteristics of UES incompetence associated with objectively documented pharyngeal reflux. The…

GERD

Estimated

~$10 – $750

Actual pay is set by the research site.

Medical College of WisconsinNCT05696184

Clinical Data Registry of Amblyopia Patients on Luminopia Treatment

Amblyopia is the most prevalent cause of reduced monocular visual acuity in children and young adults, with estimates of prevalence ranging from 1% to 5%. The …

Amblyopia

Estimated

~$10 – $1,125

Actual pay is set by the research site.

LuminopiaNCT06429280

Prospective Evaluation of the Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction (OIED)

The purpose of this study is to evaluate the effect of opioid cessation on opioid-induced esophageal dysfunction (OIED).

Opioid-Induced Esophageal Dysfunction

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT05854303

Phase 2

Double Blind Randomized Phase 2 Placebo Controlled Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure

This Phase 2 Randomized Placebo Controlled Trial will determine if administering nebulized Dornase Alpha (rhDNase) to COVID-19 patients with respiratory failur…

Covid19

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Jon SimmonsNCT04445285

Observational

Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older Adults

Aging-related functional declines are thought to be caused by hallmark biological processes that ultimately manifest in physical, mental, and metabolic impairm…

AgingAging WellHealthy Aging

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Florida Institute for Human and Machine CognitionNCT07572266

Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 Patients

Objectives: The aim of the present study is to assess the significance of metabolomics and genetics in diagnosing and survival evaluation for pNET in the peri…

Multiple Endocrine Neoplasia

Estimated

~$10 – $750

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT03048266

Investigating Health Impacts of Exposure to Harmful Algal Blooms

The goals of this project are to study the biological effects of environmental toxins (ET), in particular aquatic toxins such as brevetoxins (PbTx) and microcy…

Red TideNeurologic DisorderFlorida

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Roskamp Institute Inc.NCT06883227

Phase 2

Repurposing Valsartan May Protect Against Pulmonary Hypertension

This is a Phase 2, single-center, randomized placebo controlled trial of valsartan (an angiotensin receptor blocker) in adults with pulmonary arterial hyperten…

Pulmonary Arterial HypertensionRight Heart FailureRight Ventricular Dysfunction+1 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of WashingtonNCT06053580

Phase 3

A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Lisaftoclax (APG-2575) in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (GLORA Study)

This is a global multicenter, open label, randomized, registrational phase III study to investigate the efficacy and safety of lisaftoclax in combination with …

CLL/SLL

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Ascentage Pharma Group Inc.NCT06104566

The Texas Interprofessional Pharmacogenomics (IPGx) PILOT Cohort

The investigator's primary aim is to evaluate polypharmacy-associated adverse drug reactions (ADR) in a pilot study of at-risk patients using state-of-the-art …

Adverse Drug Reaction

Estimated

~$10 – $750

Actual pay is set by the research site.

Texas A&M UniversityNCT06219720

Phase 1

A Pilot Study of a DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

The primary objective of the trial is the safety and tolerability of administering a vaccine targeting the DNAJB1-PRKACA fusion kinase, in combination with niv…

Fibrolamellar Hepatocellular Carcinoma (FLC)

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT04248569

Phase 1

A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of SAR445877 Administered as Monotherapy or in Combination With Other Anticancer Therapies in Adults With Advanced Solid Tumors

This is a Phase 1/2, open label, multiple cohort study to assess the safety and preliminary efficacy of SAR445877 as a monotherapy or in combination with other…

Solid Tumor

Estimated

~$150 – $4,500

Actual pay is set by the research site.

SanofiNCT05584670